Swedbank Ab Vera Therapeutics, Inc. Transaction History
Swedbank Ab
- $95.2 Billion
- Q3 2025
A detailed history of Swedbank Ab transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Swedbank Ab holds 50,000 shares of VERA stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$1.51 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
201Shares Held
65.2MCall Options Held
1.58MPut Options Held
358K-
Avoro Capital Advisors LLC New York, NY6.3MShares$191 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$135 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$104 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$101 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$101 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $818M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...